ライフサイエンスコーパス: sodium iodide

1 nistration of approximately 28 MBq of (124)I-sodium iodide.

2 tient administration of larger activities of sodium iodide 131I than previously permitted.

3 y coupling with AZT and O-demethylation with sodium iodide, afforded 3'-azido-3'-deoxy-5'-O-[[(1-octa

4 By in situ 1) oxidation of sodium iodide and 2) sequestration of the transiently ge

5 characteristics, and only 2 (thallium-doped sodium iodide and bismuth germanate) have found widespre

6 ith increasing glycosaminoglycan content for sodium iodide and Gd-DTPA only, diffusivity significantl

7 h significant decreases in diffusivities for sodium iodide and Gd-DTPA, with similar (but not signifi

8 ted by the presence of 10 mg/L soap, 15 mg/L sodium iodide, and 6000 mg/L sodium thiosulfate.

9 substituted by silver acetate, sodium azide, sodium iodide, and silver nitrate.

10 the corresponding sugar aldehydes through a sodium iodide-catalyzed Henry reaction with bromonitrome

11 h sodium bromide or sodium chloride, but not sodium iodide, competitively oxidized some haloalcohols

12 The camera uses a 10 x 10 cm thallium-doped sodium iodide crystal, a 2 x 2 array of 53 x 53 mm photo

13 OET clearance was monitored for 1 hr using a sodium iodide detector in 22 isolated, buffer-perfused r

14 Mechanistic explanations for the large sodium iodide effect as well as possible mechanistic pat

15 generation of hydroiodic acid from catalytic sodium iodide, employing phosphorus acid as the stoichio

16 nerated from bis(trifluoromethyl)mercury and sodium iodide] gave fused-ring 2,2-difluorocyclopropane

17 nctional CCR6, as detected by the binding of sodium iodide I 125-labeled liver and activation-regulat

18 Exposure of the as-isolated AcN2OR to sodium iodide led to reduction of the electron-donating

19 S) analysis in positive detection mode using sodium iodide (NaI) as an additive.

20 during DNA isolation is eliminated using the sodium iodide (NaI) isolation method and that the level

21 rcent of IFN-gamma(-/-) NOD.H-2h4 mice given sodium iodide (NaI)-supplemented water develop a slow on

22 Four hours after being given (123)I-sodium iodide orally, each patient received (99m)Tc-sest

23 ernal environment, as seen by an increase in sodium iodide quenching.

24 on, fluorescence-quenching experiments using sodium iodide revealed a small reduction in the extent o

25 ed diffusivities as the smallest one tested, sodium iodide, showed higher diffusivity than sodium dia

26 single-wavelength anomalous dispersion using sodium-iodide-soaked crystals and diffraction data colle

27 n diffusion of three common contrast agents: sodium iodide, sodium diatrizoate, and gadolinium diethy

28 Mixing copper(II) perchlorate and sodium iodide solutions results in copper(I) species and

29 We incorporated the human sodium iodide symporter (hNIS) and the human somatostati

30 differentiation, including the loss of human sodium iodide symporter (hNIS) expression, radioactive i

31 carcinoembryonic antigen (CEA) or the human sodium iodide symporter (hNIS) for oncolytic potential i

32 ionuclide accumulation mediated by the human sodium iodide symporter (hNIS) gene in conjunction with

33 ntification of cardiac gene expression after sodium iodide symporter (hNIS) gene transfer in cardiac

34 ic vaccinia virus, GLV-1h153, carrying human sodium iodide symporter (hNIS), in combination with radi

35 virus (VSV)-murine interferon beta (IFNbeta)-sodium iodide symporter (NIS) (VSV-mIFNbeta-NIS) oncolyt

36 second strategy involves transduction of the sodium iodide symporter (NIS) and free radionuclide ther

37 cells with retroviral vectors containing the sodium iodide symporter (NIS) and thyroperoxidase (TPO)

38 aft breast cancer model expressing the human sodium iodide symporter (NIS) as a reporter.

39 The application of sodium iodide symporter (NIS) as a theranostic gene allo

40 In the current study, we used the sodium iodide symporter (NIS) as a theranostic gene to i

41 cancer cells to express functionally active sodium iodide symporter (NIS) by targeted NIS gene trans

42 ast cancer cells stably expressing the human sodium iodide symporter (NIS) fused to a red fluorescent

43 n the matrix protein and expresses the human sodium iodide symporter (NIS) gene.

44 its binding factor PBF repress expression of sodium iodide symporter (NIS) messenger RNA (mRNA), and

45 In this study, sodium iodide symporter (NIS) transgene imaging was eval

46 cancer cells to express functionally active sodium iodide symporter (NIS) would enable those cells t

47 din-Darby canine kidney cells expressing the sodium iodide symporter (NIS), pendrin, or NIS and pendr

48 ne levels by up-regulating expression of the sodium iodide symporter (NIS), thyroid peroxidase (TPO),

49 is one of the most promising candidates for sodium iodide symporter (NIS)-mediated gene therapy.

50 receptor expressing cells also expressed the sodium iodide symporter and thyroglobulin genes.

51 Sodium iodide symporter expression in patient tumors aft

52 MV engineered to express the sodium iodide symporter gene (MV-NIS) facilitates locali

53 profound inhibition of the expression of the sodium iodide symporter gene.

54 ted with a vaccinia virus carrying the human sodium iodide symporter GLV-1h153.

55 isease, based on decreased expression of the sodium iodide symporter SLC5A5 (NIS), diminished membran

56 A levels for thyroglobulin, thyroperoxidase, sodium iodide symporter, and deiodinase type 2, and deio

57 2, sodium hydrogen exchanger 3, aquaporin 7, sodium iodide symporter, and hydrogen potassium adenosin

58 Pax-8, thereby suppressing expression of the sodium iodide symporter, thyroid peroxidase, TG, and thy

59 thyroid-specific target genes thyroglobulin, sodium iodide symporter, thyroperoxidase, and thyroid-st

60 Anion transport by the human sodium-iodide symporter (hNIS) is an established target

61 man norepinephrine transporter (hNET), human sodium-iodide symporter (hNIS), a human deoxycytidine ki

62 We examined the sodium-iodide symporter (NIS), which promotes in vivo ce

63 h uptake into thyroid tissue mediated by the sodium-iodide symporter (NIS).

64 y antagonists increase the expression of the sodium-iodide symporter and uptake of iodine.

65 HR expression was required for expression of sodium-iodide symporter but was not required for thyrogl

66 this observation was the lack of detectable sodium-iodide symporter expression in TSHR-KO thyroid gl

67 BLI and sodium-iodide symporter imaging may be useful for in viv

68 nal obtained by firefly luciferase and human sodium-iodide symporter labeling of cardiosphere-derived

69 virus type I thymidine kinase and the human sodium-iodide symporter.

70 yroid-stimulating hormone in stimulating the sodium-iodide symporter.

71 as attributed to decreased expression of the sodium-iodide symporter.

72 novel PET radioligand for imaging the human sodium/iodide symporter (hNIS).

73 t tissue and some breast cancers express the sodium/iodide symporter (NIS) and concentrate iodide.

74 The sodium/iodide symporter (NIS) concentrates iodide in the

75 The sodium/iodide symporter (NIS) has been identified as an

76 Perchlorate, thiocyanate, and nitrate are sodium/iodide symporter (NIS) inhibitors that block iodi

77 The sodium/iodide symporter (NIS) is under investigation as

78 The sodium/iodide symporter (NIS) mediates active I(-) trans

79 The sodium/iodide symporter (NIS) mediates active iodide (I(

80 The sodium/iodide symporter (NIS) stimulates iodide uptake i

81 ds to the 3'-untranslated region of PAX8 and sodium/iodide symporter (NIS), leading to impaired prote

82 wn that RET/PTC1 decreases expression of the sodium/iodide symporter (NIS), the molecule that mediate

83 in the thyroid and breast is mediated by the sodium/iodide symporter (NIS).

84 functional role in tumor progression of the sodium/iodide symporter (NIS; aka SLC5A5), which is upre

85 The rat sodium/iodide symporter gene (rNIS) was cloned into a re

86 Here we show that a specialized form of the sodium/iodide symporter in the mammary gland mediates ac

87 hese results indicate that the mammary gland sodium/iodide symporter may be an essential breast cance

88 The sodium/iodide symporter mediates active iodide transport

89 sed expression of thyroglobulin (Tg) and the sodium/iodide symporter).

90 the hormonal regulation of the mammary gland sodium/iodide symporter, we demonstrate by scintigraphy

91 egulated expression of thyroglobulin and the sodium/iodide symporter.

92 The addition of sodium iodide to catalysts 2a-4a (to form 2b-4b in situ)

93 /6 mice) of various ages were measured using sodium iodide to prevent oxidative damage to DNA during

94 Addition of 1 equiv of sodium iodide to the reaction improved the chemoselectiv

95 ogenic anion that competitively inhibits the sodium iodide transporter and has been detected in forag

96 ng hormone receptor, thyroid peroxidase, and sodium iodide transporter.

97 luorine 18 fluorodeoxyglucose and iodine 131 sodium iodide were generated.

98 1 h plus an additional separation step using sodium iodide which can be used to reduce mineral residu

99 ormation of the CF2I group is based on using sodium iodide, with the sodium serving as a scavenger of

100 of one methyl group from the triesters with sodium iodide yielded monosodium salts, whereas treatmen